G84224TW

Summary
GlyTouCan ID
G84224TW
IUPAC Condensed
Gal(b1-4)Glc(b1-
Motifs
Lactosylceramide
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
342.12
BCSDB
GlyGen
GlycoChemExplorer
GlycoEpitope
JCGGDB AIST
KEGG GLYCAN
SugarBindDB
UniCarbKB
ChEBI
PubChem Compound
PubChem Substance
The Human Metabolome Database
3D Structures
GlycoNAVI
G84224TW
GlycoShape
G84224TW
GLYCAM
DGalpb1-4DGlcpb1-OH
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying entries 1 - 5 of 7 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
B4GALT5 (not applicable)
G71142DF
Ceramide
G84224TW
Ceramide
ST3GAL5 CMP-Neu5Ac
G84224TW
ceramide
G91237TK
ceramide
FUT5 GDP-Fuc
G84224TW
R
G57548NB
R
B4GALT6 UDP-Gal
G71142DF
Cer
G84224TW
Cer
A4GALT UDP-Gal
G84224TW
Cer
G00059MO
Cer
Displaying entries 1 - 5 of 21 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
B4GALT5 (not applicable)
G71142DF
Ceramide
G84224TW
Ceramide
ST3GAL3 CMP-Neu5Ac
G84224TW
free
G91237TK
free
ST6GAL1 CMP-Neu5Ac
G84224TW
free
G28868ZC
free
ST3GAL4 CMP-Neu5Ac
G84224TW
free
G91237TK
free
ST3GAL5 CMP-Neu5Ac
G84224TW
ceramide
G91237TK
ceramide
Displaying entries 1 - 5 of 20 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Reference
ST8SIA3 CMP-Neu5Ac
G84224TW
Cer
ST3GAL6 CMP-Neu5Ac
G84224TW
ceramide
ST6GAL1 CMP-Neu5Ac
G84224TW
ceramide
ST8SIA6 CMP-Neu5Ac
G84224TW
ST3GAL1 CMP-Neu5Ac
G84224TW
free
GlycoEpitope
Epitope ID
EP0078
Epitope Name
Lactosylceramide
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2b:b-dgal-HEX-1:5
LIN
1:1o(4+1)2d
WURCS
WURCS=2.0/2,2,1/[a2122h-1b_1-5][a2112h-1b_1-5]/1-2/a4-b1
PubAnnotation
Displaying entries 1 - 5 of 10 in total
Title Authors Source Publication Date PubMed ID
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease.
  • Salihovic S
  • Nyström N
  • Mathisen CB
  • Kruse R
  • Olbjørn C
  • Andersen S
  • Noble AJ
  • Dorn-Rasmussen M
  • Bazov I
  • Perminow G
  • Opheim R
  • Detlie TE
  • Huppertz-Hauss G
  • Hedin CRH
  • Carlson M
  • Öhman L
  • Magnusson MK
  • Keita ÅV
  • Söderholm JD
  • D'Amato M
  • Orešič M
  • Wewer V
  • Satsangi J
  • Lindqvist CM
  • Burisch J
  • Uhlig HH
  • Repsilber D
  • Hyötyläinen T
  • Høivik ML
  • Halfvarson J
Nat Commun 2024 Jun 3 38830848
Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry.
  • Scherer M
  • Böttcher A
  • Schmitz G
  • Liebisch G
Biochim Biophys Acta 2011 Feb 21081176
Sphingolipid transport in mitotic HeLa cells.
  • Collins RN
  • Warren G
J Biol Chem 1992 Dec 5 1447226
Biosynthesis of the blood group Pk and P1 antigens by human kidney microsomes.
  • Bailly P
  • Piller F
  • Gillard B
  • Veyrières A
  • Marcus D
  • Cartron JP
Carbohydr Res 1992 Apr 10 1516091
A monoclonal antibody for terminal beta-galactose. Use in analysis of glycosphingolipids.
  • Kalisiak A
  • Oosterwijk E
  • Minniti JG
  • Old LJ
  • Scheinberg DA
Glycoconj J 1991 Feb 1726670

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.1

Last updated: February 17, 2025